Take Control of Your Cancer Treatment Journey with KRAS Mutation Screening
When facing a cancer diagnosis, uncertainty about treatment effectiveness can be overwhelming. We understand the anxiety that comes with not knowing if a particular therapy will work for your specific cancer type. Our KRAS Mutation Screening provides the clarity you need to make confident treatment decisions, giving you and your healthcare team valuable insights into your cancer’s genetic profile.
Understanding KRAS Mutation Screening
The KRAS gene plays a crucial role in cell growth and division. When mutations occur in specific areas called codons 12 and 13, they can drive cancer growth and affect how your body responds to certain targeted therapies. This screening identifies these specific mutations, providing essential information that helps your oncologist determine the most effective treatment approach for your unique situation.
Using advanced Sanger Sequencing technology, we analyse tumour tissue samples with exceptional accuracy, ensuring reliable results that form the foundation of your personalised treatment plan.
Who Should Consider KRAS Mutation Screening?
This screening is particularly important for individuals diagnosed with or being treated for:
- Colorectal cancer patients considering targeted therapy options
- Lung cancer patients where KRAS status impacts treatment selection
- Pancreatic cancer patients seeking personalised treatment approaches
- Individuals whose current treatment isn’t producing expected results
- Patients wanting to explore all available targeted therapy options
- Those seeking confirmation before starting expensive biological treatments
If you’re discussing targeted therapies with your oncologist, this screening provides the genetic information needed to make informed decisions together.
Why KRAS Screening Matters for Your Health Journey
Knowing your KRAS mutation status offers significant benefits that can positively impact your treatment experience:
- Avoid ineffective treatments: Identify therapies unlikely to work, saving you from unnecessary side effects and costs
- Personalised care: Receive treatments specifically tailored to your cancer’s genetic makeup
- Better outcomes: Increase the likelihood of treatment success by choosing the right approach from the start
- Reduced anxiety: Make treatment decisions with confidence based on scientific evidence
- Time savings: Get results within 7-8 days, allowing prompt treatment adjustments if needed
- Cost efficiency: Potentially avoid spending on treatments that won’t benefit your specific cancer type
Understanding Your Results with Confidence
We know waiting for genetic test results can be stressful. Our comprehensive report provides clear, easy-to-understand information about your KRAS mutation status. Your results will indicate whether mutations are present in codons 12 or 13, and our team ensures you receive proper guidance on what these findings mean for your treatment options.
Your oncologist will use these results to discuss the most appropriate treatment strategies, helping you feel more in control of your healthcare decisions. Remember, genetic information is just one piece of your overall treatment puzzle, and your medical team will consider all factors when planning your care.
Transparent Pricing – Exceptional Value
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| KRAS Mutation Screening | ZAR 3,500 | ZAR 1,200 |
Turnaround time: 7-8 days | Sample type: Tumour tissue
Considering the potential to avoid ineffective treatments costing tens of thousands of rands, this screening represents exceptional value in your cancer care journey.
Why Trust Oracle Genomics?
We’ve built our reputation on providing reliable, accurate genetic testing that South Africans can depend on:
- Nationwide coverage: Accessible testing centres across Johannesburg, Cape Town, Durban, Pretoria and major cities
- Medical expertise: Specialised oncology genetics focus with gynecologist oversight
- Proven methodology: Sanger Sequencing technology ensures reliable, validated results
- Patient-focused approach: Clear communication and support throughout your testing journey
- Quality assurance: Rigorous quality control measures for every test
- Local understanding: Designed specifically for South African healthcare needs
Take the Next Step Toward Personalised Cancer Care
Don’t leave your treatment success to chance. With KRAS Mutation Screening, you gain the genetic insights needed to pursue the most effective treatment path for your specific cancer.
Ready to get started? Bring your doctor’s prescription and tumour tissue sample to any of our nationwide locations. Our team will guide you through the simple process and ensure you receive your results promptly.
Note: A doctor’s prescription is required for this test. Prescription requirements do not apply for surgery, pregnancy cases, or international travel planning.
Early genetic insights can make all the difference in your treatment journey. Book your KRAS Mutation Screening today and take control of your cancer care with confidence.
